| Jerome Penaflor, LVN | |
|
2051 Shadetree Ln, Escondido, CA 92029-5304 | |
| (858) 354-6978 | |
| (760) 294-5595 |
| Full Name | Jerome Penaflor |
|---|---|
| Gender | Male |
| Speciality | Licensed Practical Nurse |
| Location | 2051 Shadetree Ln, Escondido, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750573523 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 195969 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jerome Penaflor, LVN 2051 Shadetree Ln, Escondido, CA 92029-5304 Ph: (858) 354-6978 | Jerome Penaflor, LVN 2051 Shadetree Ln, Escondido, CA 92029-5304 Ph: (858) 354-6978 |
News Archive
Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced financial results for the three and six months ended June 30, 2010.
SafeStitch Medical, Inc. announced today that it has received CE Mark authorization to commercialize its AMID StaplerTM in the European Economic Community. The new stapler is to be used for fixation of mesh in the repair of hernia defects and also for the approximation of tissues, including skin. The AMID Stapler™ is the first surgical stapler designed specifically for use in inguinal hernia repairs using the Lichtenstein method, in which mesh is implanted for reinforcement. SafeStitch announced in November 2009 that it had received 510(k) clearance from the Food and Drug Administration for sale of the AMID StaplerTM in the U.S. market.
A first-in-class sphingosine kinase 2 inhibitor slowed the growth of castration-resistant prostate cancer cells, in part by inhibiting the enzyme dihydroceramide desaturase (DEGS), but did not kill them, according to the results of preclinical in vitro and in vivo studies published in the December 2015 issue of Molecular Cancer Therapeutics by researchers at the Medical University of South Carolina and others.
A new study describes the use of a single dose of vaccine based on the viral protein called the receptor-binding domain (RBD) to elicit powerful neutralizing activity against both the Wuhan strain and the most concerning VOC called the South African (SA) strain.
› Verified 4 days ago
Brandi Lynne Newman, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 910 E Ohio Ave Ste 104, Escondido, CA 92025 Phone: 760-745-7786 | |
Bonnie Haragos, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 518 S Citrus Ave, Escondido, CA 92027 Phone: 760-738-8958 | |
Ms. Lisa Violette Bartholomew, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 910 E Ohio Ave Ste 104, Escondido, CA 92025 Phone: 760-745-7786 Fax: 760-745-1061 | |
Vanessa Reyes, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 490 N Grape St, Escondido, CA 92025 Phone: 760-975-9939 |